These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 18044788

  • 1. Validation of limited sampling strategy for the estimation of mycophenolic acid exposure in Chinese adult liver transplant recipients.
    Hao C, Erzheng C, Anwei M, Zhicheng Y, Baiyong S, Xiaxing D, Weixia Z, Chenghong P, Hongwei L.
    Liver Transpl; 2007 Dec; 13(12):1684-93. PubMed ID: 18044788
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Limited sampling strategy for the estimation of mycophenolic acid area under the plasma concentration-time curve in adult patients undergoing liver transplant.
    Zicheng Y, Weixia Z, Hao C, Hongzhuan C.
    Ther Drug Monit; 2007 Apr; 29(2):207-14. PubMed ID: 17417076
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Models for the prediction of mycophenolic acid area under the curve using a limited-sampling strategy and an enzyme multiplied immunoassay technique in Chinese patients undergoing liver transplantation.
    Chen H, Gu Z, Chen B, Mao H, Zhang W, Fan Q.
    Clin Ther; 2008 Dec; 30(12):2387-401. PubMed ID: 19167597
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of mycophenolic acid and determination of area under the curve by abbreviated sampling strategy in Chinese liver transplant recipients.
    Chen H, Peng C, Yu Z, Shen B, Deng X, Qiu W, Fei Y, Shen C, Zhou G, Yang W, Li H.
    Clin Pharmacokinet; 2007 Dec; 46(2):175-85. PubMed ID: 17253887
    [Abstract] [Full Text] [Related]

  • 9. Limited sampling models and Bayesian estimation for mycophenolic acid area under the curve prediction in stable renal transplant patients co-medicated with ciclosporin or sirolimus.
    Musuamba FT, Rousseau A, Bosmans JL, Senessael JJ, Cumps J, Marquet P, Wallemacq P, Verbeeck RK.
    Clin Pharmacokinet; 2009 Dec; 48(11):745-58. PubMed ID: 19817503
    [Abstract] [Full Text] [Related]

  • 10. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO, Ehlermann P, Koch A, Remppis A, Katus HA, Dengler TJ.
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Limited Sampling Strategy for Estimating Mycophenolic Acid Exposure on Day 7 Post-Transplant for Two Mycophenolate Mofetil Formulations Derived From 20 Chinese Renal Transplant Recipients.
    Cai W, Cai Q, Xiong N, Qin Y, Lai L, Sun X, Hu Y.
    Transplant Proc; 2018 Jun; 50(5):1298-1304. PubMed ID: 29735215
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Limited Sampling Strategy for Mycophenolic Acid in Chinese Kidney Transplant Recipients Receiving Enteric-Coated Mycophenolate Sodium and Tacrolimus During the Early Posttransplantation Phase.
    Yao X, Huang H, Wei C, Chen Y, Peng W, Xie W, Chen J.
    Ther Drug Monit; 2015 Aug; 37(4):516-23. PubMed ID: 25565669
    [Abstract] [Full Text] [Related]

  • 15. Development and validation of limited sampling strategies for tacrolimus and mycophenolate in steroid-free renal transplant regimens.
    Poulin E, Greanya ED, Partovi N, Shapiro RJ, Al-Khatib M, Ensom MH.
    Ther Drug Monit; 2011 Feb; 33(1):50-5. PubMed ID: 21157401
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of mycophenolic acid exposure using a limited sampling strategy in renal transplant recipients.
    Li J, Liu Y, Huang J, Fu Q, Chen E, Liu L, Zhang R, Huang M, Wang C.
    Am J Nephrol; 2013 Feb; 37(6):534-40. PubMed ID: 23689735
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of the practicability of limited sampling strategies for the estimation of mycophenolic acid exposure in Chinese adult renal recipients.
    Zicheng Y, Xianghui W, Peijun Z, Da X, Weixia Z, Hongzhuan C.
    Ther Drug Monit; 2007 Oct; 29(5):600-6. PubMed ID: 17898650
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of limited sampling strategies for mycophenolic acid after mycophenolate mofetil intake in adult kidney transplant recipients.
    Barraclough KA, Isbel NM, Franklin ME, Lee KJ, Taylor PJ, Campbell SB, Petchey WG, Staatz CE.
    Ther Drug Monit; 2010 Dec; 32(6):723-33. PubMed ID: 21068647
    [Abstract] [Full Text] [Related]

  • 20. Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.
    Pawinski T, Durlik M, Szlaska I, Urbanowicz A, Majchrnak J, Gralak B.
    J Clin Pharm Ther; 2006 Feb; 31(1):27-34. PubMed ID: 16476117
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.